trending Market Intelligence /marketintelligence/en/news-insights/trending/lhtwkz__9eohfzotq2hkvg2 content esgSubNav
In This List

Zai Lab prices offering of American depositary shares

Blog

Insight Weekly: Banks brace for recession; Europe PE deal values soar; US solar imports rebound

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook


Zai Lab prices offering of American depositary shares

Zai Lab Ltd. priced an underwritten public offering of 7.5 million American depositary shares at $20 each.

Each ADS represents an ordinary share of the Shanghai-based biopharmaceutical company.

Zai Lab expects to raise gross proceeds of about $150 million through the offering, which is expected to close Sept. 10, subject to customary closing conditions.

Underwriters have 30-day option to buy up to an additional 1,125,000 ADSs at the offering price.

J.P. Morgan, Citigroup, Jefferies and Leerink Partners are acting as joint book-running managers for the offering.